12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing β cells and involves an interplay between β cells and cells of the innate and adaptive immune systems. We investigated the therapeutic potential of targeting 12-lipoxygenase (12-LOX), an enzyme implicated in in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Titli Nargis, Charanya Muralidharan, Jacob R. Enriquez, Jiayi E. Wang, Kerim B. Kaylan, Advaita Chakraborty, Sarida Pratuangtham, Kayla Figatner, Jennifer B. Nelson, Sarah C. May, Jerry L. Nadler, Matthew B. Boxer, David J. Maloney, Sarah A. Tersey, Raghavendra G. Mirmira
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Clinical investigation 2024-12-01
Serier:JCI Insight
Fag:
Endocrinology
Therapeutics
Online adgang:https://doi.org/10.1172/jci.insight.185299
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker